Principal Financial Group’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $82.5K | Buy |
+10,141
| New | +$91.9K | ﹤0.01% | 2130 |
|
|
2025
Q4 | – | Sell |
-11,386
| Closed | -$98.7K | – | 2242 |
|
|
2025
Q3 | $98.7K | Buy |
11,386
+806
| +8% | +$6.27K | ﹤0.01% | 2194 |
|
|
2025
Q2 | $66.7K | Sell |
10,580
-1,333
| -11% | -$8.83K | ﹤0.01% | 2183 |
|
|
2025
Q1 | $76.4K | Sell |
11,913
-274
| -2% | -$2.27K | ﹤0.01% | 2111 |
|
|
2024
Q4 | $98K | Sell |
12,187
-232
| -2% | -$2.24K | ﹤0.01% | 2151 |
|
|
2024
Q3 | $157K | Sell |
12,419
-11,178
| -47% | -$144K | ﹤0.01% | 2122 |
|
|
2024
Q2 | $299K | Sell |
23,597
-3,090
| -12% | -$31.1K | ﹤0.01% | 2057 |
|
|
2024
Q1 | $128K | Buy |
26,687
+1,966
| +8% | +$9.12K | ﹤0.01% | 2248 |
|
|
2023
Q4 | $119K | Buy |
24,721
+1,219
| +5% | +$7.46K | ﹤0.01% | 2245 |
|
|
2023
Q3 | $170K | Buy |
23,502
+71
| +0.3% | +$567 | ﹤0.01% | 2191 |
|
|
2023
Q2 | $174K | Buy |
23,431
+3,422
| +17% | +$26.9K | ﹤0.01% | 2203 |
|
|
2023
Q1 | $139K | Sell |
20,009
-1,856
| -8% | -$17.1K | ﹤0.01% | 2242 |
|
|
2022
Q4 | $225K | Buy |
21,865
+3,942
| +22% | +$69.6K | ﹤0.01% | 2169 |
|
|
2022
Q3 | $326K | Sell |
17,923
-1,396
| -7% | -$60.5K | ﹤0.01% | 2061 |
|
|
2022
Q2 | $994K | Buy |
19,319
+1,530
| +9% | +$79.3K | ﹤0.01% | 1920 |
|
|
2022
Q1 | $1.31M | Sell |
17,789
-1,045
| -6% | -$93.2K | ﹤0.01% | 1930 |
|
|
2021
Q4 | $2.69M | Sell |
18,834
-27,815
| -60% | -$4.78M | ﹤0.01% | 1815 |
|
|
2021
Q3 | $9.67M | Buy |
46,649
+22,033
| +90% | +$4.86M | 0.01% | 1416 |
|
|
2021
Q2 | $5.23M | Buy |
24,616
+2,745
| +13% | +$503K | ﹤0.01% | 1700 |
|
|
2021
Q1 | $3.96M | Buy |
21,871
+2,148
| +11% | +$428K | ﹤0.01% | 1728 |
|
|
2020
Q4 | $2.2M | Buy |
19,723
+4,527
| +30% | +$481K | ﹤0.01% | 1782 |
|
|
2020
Q3 | $1.65M | Sell |
15,196
-1,832
| -11% | -$223K | ﹤0.01% | 1771 |
|
|
2020
Q2 | $1.42M | Buy |
+17,028
| New | +$651K | ﹤0.01% | 1759 |
|
|
2019
Q2 | – | Sell |
-5,164
| Closed | -$57K | – | 2256 |
|
|
2019
Q1 | $57K | Buy |
5,164
+65
| +1% | +$2.05K | ﹤0.01% | 2180 |
|
|
2018
Q4 | $188K | Sell |
5,099
-152
| -3% | -$5.89K | ﹤0.01% | 2138 |
|
|
2018
Q3 | $197K | Buy |
5,251
+247
| +5% | +$6.96K | ﹤0.01% | 2175 |
|
|
2018
Q2 | $135K | Buy |
5,004
+233
| +5% | +$7.88K | ﹤0.01% | 2203 |
|
|
2018
Q1 | $200K | Buy |
4,771
+392
| +9% | +$15.7K | ﹤0.01% | 2110 |
|
|
2017
Q4 | $109K | Buy |
4,379
+2,405
| +122% | +$58.7K | ﹤0.01% | 2180 |
|
|
2017
Q3 | $45K | Sell |
1,974
-383
| -16% | -$8.57K | ﹤0.01% | 2187 |
|
|
2017
Q2 | $54K | Sell |
2,357
-48
| -2% | -$942 | ﹤0.01% | 2228 |
|
|
2017
Q1 | $62K | Hold |
2,405
| – | – | ﹤0.01% | 2168 |
|
|
2016
Q4 | $61K | Hold |
2,405
| – | – | ﹤0.01% | 2189 |
|
|
2016
Q3 | $100K | Buy |
2,405
+27
| +1% | +$3.49K | ﹤0.01% | 2101 |
|
|
2016
Q2 | $346K | Buy |
2,378
+22
| +0.9% | +$2.52K | ﹤0.01% | 1907 |
|
|
2016
Q1 | $243K | Buy |
2,356
+36
| +2% | +$3.86K | ﹤0.01% | 1977 |
|
|
2015
Q4 | $389K | Buy |
2,320
+17
| +0.7% | +$2.62K | ﹤0.01% | 1895 |
|
|
2015
Q3 | $326K | Sell |
2,303
-8
| -0.3% | -$1.79K | ﹤0.01% | 1934 |
|
|
2015
Q2 | $515K | Buy |
2,311
+414
| +22% | +$72.8K | ﹤0.01% | 1874 |
|
|
2015
Q1 | $314K | Sell |
1,897
-25
| -1% | -$4.06K | ﹤0.01% | 1907 |
|
|
2014
Q4 | $228K | Sell |
1,922
-616
| -24% | -$64.4K | ﹤0.01% | 2008 |
|
|
2014
Q3 | $212K | Buy |
2,538
+363
| +17% | +$32.8K | ﹤0.01% | 2018 |
|
|
2014
Q2 | $201K | Sell |
2,175
-406
| -16% | -$35.7K | ﹤0.01% | 2090 |
|
|
2014
Q1 | $234K | Sell |
2,581
-24
| -0.9% | -$2.68K | ﹤0.01% | 2085 |
|
|
2013
Q4 | $267K | Buy |
+2,605
| New | +$184K | ﹤0.01% | 2051 |
|
|
2013
Q3 | – | Sell |
-3,544
| Closed | -$145K | – | 2286 |
|
|
2013
Q2 | $145K | Buy |
+3,544
| New | +$154K | ﹤0.01% | 2151 |
|
Other funds holding NVAX
SCM
VPM
VCM
S
Principal Financial Group's NVAX Position: Q1 2026 in Review
Principal Financial Group opened a new position in Novavax (NVAX) in Q1 2026: 10,141 shares worth $82.5K. The stake represents ﹤0.01% of the portfolio and ranks #2130 among its holdings. This is a return to the name: Principal Financial Group previously reported a position in NVAX as recently as Q3 2025.
Principal Financial Group first reported a position in NVAX in Q2 2013 and has held it in 46 quarters since. The position peaked at $9.67M in Q3 2021. 257 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.
- Principal Financial Group held 10,141 shares of Novavax worth $82.5K as of Q1 2026.
- Novavax was a new Principal Financial Group position in Q1 2026.
- Novavax made up ﹤0.01% of Principal Financial Group's portfolio in Q1 2026, its #2130 holding.
- Principal Financial Group first reported a position in Novavax in Q2 2013 and has held it in 46 quarters since.
- Principal Financial Group's Novavax position peaked at $9.67M in Q3 2021.
- 257 funds tracked by Wall St. Rank held Novavax as of Q1 2026.
Based on Principal Financial Group's 13F filing for Q1 2026, filed 4 May 2026.